APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, the co-injection of a 1:1 mixture resulted in the least apoptosis (~79% less apoptosis than the CML-alone group), while the apoA-I-alone (1:0) group showed no significant reduction: ~15% lower than the CML+PBS group.